Abstract
This study aimed to evaluate the anti-cariogenic potential of S. salivarius G7, a probiotic candidate. The antimicrobial activity of S. salivarius G7 against S. mutans was evaluated using a susceptibility assay, and its efficacy against S. mutans biofilm was assessed by confocal laser scanning microscopy (CLSM) and cultivation. The effect of S. salivarius G7 on the expression of glucosyltransferase (gtf) genes was examined by real-time reverse transcription-polymerase chain reaction (RT-PCR). Cariogenic biofilm models were also employed to investigate ecological effects. S. salivarius G7 inhibited the growth of S. mutans in a concentration-dependent manner and significantly reduced biofilm biomass and viable cell counts during biofilm development; however, it showed limited efficacy in disrupting mature biofilms. Gene expression analysis revealed a 20% - 35% reduction in the expression levels of gtf B, gtf C, and gtf D. In saliva-derived biofilms, treatment with S. salivarius G7 selectively decreased S. mutans abundance and enhanced S. salivarius colonization without altering total bacterial load. These findings demonstrate that S. salivarius G7 exerts anti-cariogenic effects by inhibiting growth, suppressing biofilm formation, downregulating glucan-related gene expression, and modulating microbial composition. The results support its potential as an oral probiotic for dental caries prevention.
Keywords: Dental caries, Streptococcus mutans, Streptococcus salivarius G7, Oral probiotics
Introduction
Dental caries is one of the most prevalent chronic diseases worldwide, affecting both children and adults. Among the diverse oral microbiota,
Streptococcus mutans is considered a key pathogen[
1]. Its cariogenic properties stem from its strong acidogenicity and aciduricity, which allow it to flourish in acidic environments. Furthermore, its ability to synthesize extracellular glucans facilitates biofilm formation, enhancing the bacterium’s ability to adhere to and persist on tooth surfaces[
2,
3].
Traditional strategies for caries prevention include mechanical plaque control, fluoride application, and antimicrobial agents[
4]. However, the extensive use of antibiotics or antiseptics may disrupt the ecological balance of the oral microbiome and contribute to antimicrobial resistance[
5]. Consequently, the concept of probiotics—the use of beneficial bacteria to modulate the oral environment—has gained increasing attention in recent years[
6,
7].
Streptococcus salivarius , an early colonizer of the oral cavity and a constituent of the normal oral microbiome, has recently been highlighted for its probiotic potential[
8]. Certain
S. salivarius strains release bacteriocin-like inhibitory substances (BLIS) and other metabolites that can suppress pathogenic bacteria, including
S. mutans [
9,
10]. In particular, K12 and M18 strains have been examined for their ability to reduce oral malodor, pharyngitis, and caries risk[
11,
12].
S. salivarius G7, isolated from a subgingival sample of a healthy Korean man, has been proposed as a promising candidate for oral probiotic applications.
Therefore, this study aimed to evaluate the anticariogenic efficacy of S. salivarius G7 by assessing its inhibitory effects on the growth and biofilm formation of S. mutans , analyzing its influence on the expression of glucosyltransferase (gtf) genes involved in glucan synthesis, and investigating its effects on the microbial composition of saliva-derived biofilms.
Materials and Methods
1. Bacterial strains and cultivation
S. salivarius G7 (formerly KCOM 2137) was donated by Greenstore Co. (Seongnam, Korea) and preserved in trypticase soy broth (TSB; BD Biosciences, Sparks, MD, USA). S. mutans ATCC 25175 was used in susceptibility assays and for cariogenic biofilm formation. S. mutans was cultured in TSB at 37℃, and biofilms were formed in brain heart infusion (BHI; BD Biosciences) broth supplemented with 1% sucrose at 37℃.
2. Susceptibility of S. mutans to S. salivarius G7
The susceptibility of S. mutans to the spent culture medium (SCM) of S. salivarius G7 was examined following the Clinical and Laboratory Standards Institute (CLSI) guidelines. SCM was obtained by centrifugation at 6,000 × g for 10 min at 4℃ and filtered through a 0.22 μm syringe filter. TSB was dispensed into a 96-well plate (SPL Life Sciences, Pocheon, Korea), and 180 μL of SCM was added to the first column well of a 96-well plate. The SCM was then serially two-fold diluted across columns 1 to 12. S. mutans cells were enumerated using a Petroff-Hausser counting chamber (Hausser Scientific, Horsham, PA, USA) and diluted to 1 × 106 cells/mL with BHI broth.
A 20 μL aliquot of the diluted suspension was inoculated into each well. Plates were incubated at 37℃ for 36 h, and optical density (OD) was measured at 660 nm using a spectrophotometer.
3. Formation of cariogenic biofilm by S. mutans
S. mutans (1 × 106 CFU/mL) was inoculated into 5 mL of fresh BHI broth supplemented with 1% sucrose with or without S. salivarius SCM at a concentration of an 8- to 16-fold dilution. Then, 2 mL of the inoculated mixture was dispensed into an 8-well glass chamber (BD Biosciences) and a 12-well plate (SPL Life Sciences). The plates were incubated at 37℃ for 72 h, with media replaced daily under the same conditions. After biofilm formation, the plates were washed three times with phosphate-buffered saline (PBS; Sigma-Aldrich, St. Louis, MO, USA) to remove planktonic cells. The biofilm in the 8-well glass chamber was stained using a live/dead bacterial viability kit (Invitrogen, Eugene, OR, USA) and analyzed by confocal laser scanning microscopy (CLSM; Carl Zeiss, Oberkochen, Germany) using z-stack scans from 0 to 30 μm. In the 12-well plate, biofilms were disrupted with a cell scraper (SPL Life Sciences), and the suspensions were serially diluted 10-fold up to 106. The diluted suspensions were plated on Mitis salivarius bacitracin agar (MSB; BD Biosciences) and incubated at 37℃ for 48 h, before the colonies were counted. In a separate experiment, pre-formed biofilms were treated with SCM for 1 or 5 min, mechanically disrupted with a cell scraper, serially diluted 10-fold to 106, plated on MSB agar, and incubated at 37℃ for 48 h for colony enumeration.
4. Effect of S. salivarius SCM on the glucan expression of S. mutans
Glucan production by S. mutans , which is associated with biofilm formation, was indirectly analyzed by measuring the expression levels of gtf genes. S. mutans was cultured in BHI broth supplemented with 1% sucrose, with or without SCM of S. salivarius at a non-lethal concentration (16-fold dilution), for 12 h. Total RNA was extracted using the TRIzol® Max Bacterial RNA Isolation Kit (Invitrogen Life Technologies, Carlsbad, CA, USA). Complementary DNA (cDNA) was synthesized from the extracted RNA using Maxime™ RT Premix (iNtRON Biotechnology, Seongnam, Gyeonggi, Korea) in a 20 μL reaction, incubated at 45℃ for 1 h. The resulting cDNA was mixed with 10 μL of TB Green® Premix Ex Taq (Takara Bio Inc., Shiga, Japan) and 0.4 μM of each primer pair in a 50 μL final volume and subjected to 40 cycles consisting of denaturation at 94℃ for 10 s, annealing at 60℃ for 10 s, and extension at 72℃ for 33 s on an ABI 7500 real-time RT-PCR system (Applied Biosystems, Foster City, CA, USA). 16S rRNA, a housekeeping gene, was used as an internal reference to normalize expression levels and quantify changes in gtf expression between untreated and SCM-treated groups. Primer sequences for real-time RT-PCR were as follows:
gtf B: 5’-AGC AAT GCA GCC AAT CTA CAA AT-3’ and 5’-ACG AAC TTT GCC GTT ATT GTC A-3’
gtf C: 5’-CTC AAC CAA CCG CCA CTG TT-3’ and 5’-GGT TAA CGT CAA AAT TAG CTG TAT TAG C-3’
gtf D: 5’-CAC AGG CAA AAG CTG AAT TAA CA-3’ and 5’-AAT GGC CGC TAA GTC AAC AG-3’
16S rRNA: 5’-GAA AGT CTG GAG TAA AAG GCT A-3’ and 5’-GTT AGC TCC GGC ACT AAG CC-3’
5. Effect of S. salivarius on microbiome in salivary biofilm
Cariogenic biofilm was formed following the method of Lee et al.[
13]. Unstimulated saliva was collected from 10 healthy donors and pooled in equal proportions. The pooled saliva was mixed with BHI broth containing 1% sucrose and 1% mannose, and then centrifuged at 2,000 × g for 10 min at 4℃ to remove debris. The supernatant was transferred into three new tubes, and
S. mutans (1 × 10
6 cells) was added to form a cariogenic biofilm.
S. salivarius (1 × 10
7 cells) was then inoculated into each tube containing salivary bacteria. The preparation was vortexed for 10 s. Then, 1 ml of the mixture was inoculated into a conditioned 12-well plate, and 400 μL was inoculated into an 8-well glass chamber. The plates were incubated at 37℃ for 1 week, and the media were replaced daily with BHI broth supplemented with 1% sucrose, 1% mannose, and
S. salivarius (1 × 10
7 cells). For biofilm formation analysis, the 8-well glass chamber was washed three times with PBS and stained with SYTO 9 dye (Invitrogen) according to the manufacturer’s instructions. Biofilms were visualized by CLSM using z-stack scans covering 0 to 30 μm. For bacterial composition analysis, biofilms formed in the 12-well plate were washed three times with PBS to remove planktonic bacteria and disrupted in PBS. The suspension was transferred into a 1.5 mL tube, and bacteria were harvested by centrifugation at 5,000 × g for 10 min. Total bacterial DNA was extracted using the QIAamp DNA Microbiome Kit (Qiagen, Hilden, Germany) and analyzed by real-time PCR.
6. Bacterial quantification using DNA from biofilm
To generate a standard curve for bacterial quantification, bacteria were cultured and counted, and DNA was then extracted from each preparation. Total DNA from biofilms was analyzed by real-time PCR with specific primers. DNA was mixed with 25 μL of TB Green® Premix Ex Taq and 0.4 μM of each primer pair in a final volume of 50 μL and subjected to 40 cycles (94℃ for 10 s, 60℃ for 10 s, and 72℃ for 33 s) on an ABI 7500 real-time PCR system (Applied Biosystems). Primer sequences for real-time PCR were as follows:
Un iversal genes: 5’-TGG AGC ATG TGG TTT AAT TCG A-3’ and 5’-TGC GGG ACT TAA CCC AAC A-3’
St reptococcus genes: 5’-AAG CAA CGC GAA GAA CCT TA-3’ and 5’-GTC TCG CTA GAG TGC CCA AC-3’
S. mutans genes: 5’-CTA CAC TTT CGG GTG GCT TG-3’ and 5’-GAA GCT TTT CAC CAT TAG AAG CTG-3’
S. salivarius genes: 5’-TTG CCA CAT CTT CAC TCG CTT-3’ and 5’-CCT GAA TTT GGT TGA ACT GTC GTT-3’
Specific amplification was confirmed using a dissociation curve. The critical threshold cycle (Ct) was defined as the cycle at which fluorescence became detectable above the background signal. The bacterial counts were obtained by comparing the Ct values of the samples with those of the standard curve.
7. Statistical analysis
Significant differences were analyzed through Kruskal-Wallis and Mann-Whitney tests in IBM SPSS Statistics version 21 (IBM Corp., Armonk, NY, USA). P-values less than 0.05 were considered statistically significant.
Results
1. Inhibitory effect of S. salivarius G7 on S. mutans growth
The antibacterial activity of the SCM derived from
S. salivarius G7 against
S. mutans was evaluated using a broth microdilution assay. As shown in
Fig. 1,
S. mutans growth in the control group remained stable across all wells, with an OD at 660 nm of approximately 0.55 - 0.60 after 36 h of incubation. In contrast, SCM addition resulted in a concentration-dependent inhibition of
S. mutans growth. At higher dilution factors (≥ 32-fold), no significant difference was observed compared with the control. However, at an 8-fold dilution,
S. mutans growth markedly reduced, with the OD dropping to nearly half that of the control. At lower dilutions (4-2-fold), a pronounced inhibitory effect was evident, with the OD decreasing to below 0.1, indicating almost complete growth suppression. These results demonstrate that the SCM of
S. salivarius G7 exhibits potent inhibitory activity against
S. mutans , and the effect is strongly dependent on SCM concentration.
2. Inhibitory effect of S. salivarius G7 SCM on S. mutans biofilm formation
The effect of the SCM of
S. salivarius G7 on
S. mutans biofilm formation was examined using CLSM and CFU counts. As shown in
Fig. 2A, untreated
S. mutans formed a thick, continuous biofilm layer. Conversely, biofilms formed in the presence of SCM at a 8-fold dilution exhibited markedly reduced thickness and biomass, with confocal images revealing disrupted and sparse mass (
Fig. 2B).
The bacterial levels in the biofilm corroborated the microscopic observations (
Fig. 2C). The control biofilm contained approximately 6.82 × 10
6 ± 8.70 × 10
5 CFU/mL. In contrast, the 16-fold diluted SCM significantly reduced the viable cell counts to approximately 4.55 × 10
6 ± 2.17 × 10
5 CFU/mL (
p < 0.05), and the 8-fold diluted SCM further reduced counts to approximately 2.77 × 10
6 ± 3.25 × 10
5 CFU/mL (
p < 0.05). These results indicate a concentration-dependent inhibitory effect of SCM on
S. mutans biofilms.
To determine whether SCM could disrupt pre-formed biofilms, mature
S. mutans biofilms were treated with SCM for 1 or 5 min, followed by CFU enumeration (
Fig. 2D). However, no significant reduction in viable bacterial counts was observed compared with the untreated control, indicating that short-term exposure to SCM did not eradicate established biofilms.
3. Effect of S. salivarius G7 SCM on the expression of gtf in S. mutans
The expression levels of
gtf B,
gtf C, and
gtf D, which are essential for glucan synthesis and biofilm formation, were analyzed by quantitative real-time PCR. When
S. mutans was cultured in the presence of SCM at a nonlethal concentration (16-fold dilution) for 12 h, the expression of all three
gtf genes was significantly downregulated compared with the control (
Fig. 3). Specifically,
gtf B expression was reduced to approximately 65% - 70% of the control level,
gtf C to 70% - 75%, and
gtf D to 75% - 80%. These results indicate that SCM suppresses glucan synthesis in
S. mutans at the transcriptional level, providing molecular evidence for the observed reduction in biofilm formation.
4. Effect of S. salivarius G7 on the microbial composition of saliva-derived biofilms
To evaluate the effect of
S. salivarius G7 in a complex oral environment, saliva-derived biofilm models were established and analyzed by confocal microscopy and quantitative PCR. As shown in
Fig. 4, untreated control biofilms exhibited thick and dense structures with strong green fluorescence throughout the z-stack depth. In contrast, biofilms treated with
S. salivarius displayed visibly reduced density and biomass, indicating that
S. salivarius altered the structural integrity of saliva-derived biofilms.
Quantitative PCR of bacterial composition further revealed marked changes in the microbiota (
Fig. 5). The total bacterial load, determined by universal 16S primers, was not significantly different between the control and treatment groups, indicating that the overall bacterial biomass was preserved. However, the total streptococcal population decreased in the presence of
S. salivarius G7. Notably,
S. mutans counts dropped dramatically, from approximately 1.4 × 10
8 to nearly undetectable levels. In contrast, the abundance of
S. salivarius within the biofilm community significantly increased.
Discussion
Dental caries is a multifactorial disease primarily driven by the cariogenic properties of
S. mutans [
1,
2]. This study demonstrated that
S. salivarius G7, a commensal oral bacterium, exerts a marked inhibitory effect on
S. mutans through multiple mechanisms.
First, growth inhibition assays revealed a clear concentration-dependent suppression of
S. mutans by
S. salivarius G7-derived metabolites. This finding aligns with previous reporting showing that
S. salivarius secretes BLIS and other antimicrobial compounds that restrict the proliferation of pathogenic streptococci[
8,
14].
Second, biofilm assays showed that the SCM significantly reduced
S. mutans biofilm biomass and viable cell counts during biofilm development, but had minimal impact on the disruption of mature biofilms after shortterm exposure. These findings suggest that the primary role of
S. salivarius may lie in preventing biofilm formation rather than eradicating established structures. This observation highlights its potential as a preventive intervention during the early stages of biofilm formation and is consistent with earlier reports of probiotic activity in oral environments[
6,
8].
Third, molecular analysis indicated that
S. salivarius G7 SCM downregulated the expression levels of
gtf B,
gtf C, and
gtf D—genes essential for glucan synthesis and biofilm matrix development[
3]. This finding provides mechanistic evidence that
S. salivarius G7 not only inhibits
S. mutans growth but also attenuates its pathogenicity at the transcriptional level.
Finally, saliva-derived biofilm models highlighted the ecological relevance of
S. salivarius G7. The total bacterial abundance observed in the
in vitro saliva-derived biofilm (~10
9 CFU/mL) was higher than that typically found in healthy supragingival plaque (10
7 - 10
8 CFU/mL) and comparable to bacterial levels reported in advanced carious lesions[
15]. Although the total bacterial biomass remained largely unchanged, the abundance of
S. mutans was markedly reduced, whereas
S. salivarius colonization increased. This selective modulation indicates that
S. salivarius G7 can beneficially shift the oral microbial balance, reducing cariogenic potential without disturbing the overall microbiome[
6,
16]. Recent advances in metagenomics and single-cell approaches underscore the need to evaluate such ecological shifts at higher resolution, to fully understand how probiotics reshape the oral microbiome[
17].
From a clinical perspective, these findings provide additional evidence for the potential of oral probiotics in caries prevention[
18,
19]. Early colonization studies have shown that probiotic
S. salivarius strains can thrive within the oral cavity[
20], suggesting that the G7 strain may also persist and exert protective effects
in vivo .
Despite these promising results, several limitations should be acknowledged. All experiments were performed under in vitro conditions using defined media and saliva-derived biofilm models. Although such systems offer valuable insights into bacterial interactions, they cannot fully replicate the complexity of the human oral environment. In addition, the probiotic potential of S. salivarius G7 was evaluated mainly through its cell-free metabolites (SCM); thus, the contribution of live bacterial colonization and persistence in vivo remains to be clarified. Furthermore, the S. salivarius G7 strain was originally isolated from a subgingival site, whereas dental caries primarily develops on supragingival enamel surfaces. Although S. salivarius species are known to inhabit multiple oral niches, ecological differences between subgingival and supragingival environments may influence their activity. Moreover, most experiments employed a single-species S. mutans biofilm model, which simplifies the complex multispecies interactions present in vivo . While saliva-derived biofilm assays were included to partially address this limitation, future studies using polymicrobial biofilm systems will be essential to validate these findings under more clinically relevant conditions.
Additionally, the potential pH-driven effects of the SCM were not excluded in this study. Future investigations will include pH-neutralized, heat-treated, protease-treated, and catalase-treated SCM to confirm the pH-independent activity of the active components. In future studies, the mature biofilm assays will be refined to address the current limitations of brief exposure times (1 - 5 min) and the absence of a positive control such as chlorhexidine. Subsequent studies will incorporate extended dose-time responses (15 - 60 min) and appropriate positive controls to better contextualize the efficacy of S. salivarius G7 SCM against mature biofilms. Finally, quantitative biofilm indices such as COMSTAT-derived biomass, thickness, and crystal-violet biomass measurements were not included. Integrating these quantitative parameters with biological replicates and statistical analyses in future work will strengthen the interpretation of biofilm inhibition.
Conclusion
This study demonstrates that S. salivarius G7 exhibits potent anti-cariogenic activity against S. mutans under in vitro conditions. The SCM of the G7 effectively inhibited S. mutans growth and biofilm formation in a concentration-dependent manner and significantly downregulated the expression of gtf B, gtf C, and gtf D genes, which are central to biofilm matrix synthesis. Moreover, in saliva-derived biofilm models, S. salivarius G7 selectively suppressed S. mutans while maintaining overall microbial biomass and enhancing its own colonization, indicating its ability to beneficially modulate oral microbial communities.
These findings support the potential role of S. salivarius G7 as an oral probiotic for dental caries prevention. However, because this study was conducted exclusively in vitro , further investigations using in vivo models and clinical trials are needed to validate its efficacy, establish optimal delivery strategies, and assess long-term safety.